• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

亚太地区三尖瓣介入治疗的现状

Current Status of Tricuspid Valve Interventions in Asia Pacific Region.

作者信息

So Kent Chak-Yu, Xu Jianqiang, Kam Kevin Ka-Ho, Sung Shih-Hsien, Meemook Krissada, Wang Dee Dee, Tang Gilbert H L, Lee Alex Pui-Wai, Lam Yat-Yin

机构信息

Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong SAR, China.

Department of Cardiology, Tianjin First Central Hospital, Tianjin, China.

出版信息

JACC Asia. 2025 Mar;5(3 Pt 2):405-423. doi: 10.1016/j.jacasi.2024.10.008. Epub 2024 Dec 17.

DOI:10.1016/j.jacasi.2024.10.008
PMID:40148013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12042979/
Abstract

Transcatheter tricuspid interventions are becoming increasingly more common in Asia Pacific. In the past decade, clinicians in Asia Pacific have worked with a multitude of new transcatheter tricuspid technologies. A standardized clinical algorithm to diagnose symptomatic tricuspid regurgitation to increase patient access to novel right heart therapies has not yet been identified. Anatomic diversity in the Asia Pacific patient population; disease prevalence patterns; and socioeconomic, cultural, and local health structures represent unique challenges in the treatment of these patients with right heart failure. As advancements are made in right heart failure and transcatheter tricuspid technologies, hopefully more patients can be treated not just in Asia Pacific, but across the entire world.

摘要

经导管三尖瓣干预在亚太地区正变得越来越普遍。在过去十年中，亚太地区的临床医生已使用了多种新型经导管三尖瓣技术。目前尚未确定一种标准化的临床算法来诊断症状性三尖瓣反流，以增加患者获得新型右心治疗的机会。亚太地区患者人群的解剖学多样性、疾病流行模式以及社会经济、文化和当地卫生结构，对这些右心衰竭患者的治疗构成了独特挑战。随着右心衰竭和经导管三尖瓣技术的进步，有望不仅在亚太地区，而且在全世界让更多患者得到治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/2c1ac3968658/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/7b3f2eb9b7ee/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/7b3f2eb9b7ee/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/d46b4c0fe735/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/5ab08a31c5a6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/a890a9715c66/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/0d92be8e7feb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/707944899ded/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/63e34cb8ed10/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/7f036f372479/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/b8aec672a0b5/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/5769e17b8835/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/2c1ac3968658/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/7b3f2eb9b7ee/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/7b3f2eb9b7ee/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/d46b4c0fe735/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/5ab08a31c5a6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/a890a9715c66/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/0d92be8e7feb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/707944899ded/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/63e34cb8ed10/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/7f036f372479/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/b8aec672a0b5/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/5769e17b8835/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574d/12042979/2c1ac3968658/gr10.jpg

相似文献

1
Current Status of Tricuspid Valve Interventions in Asia Pacific Region.亚太地区三尖瓣介入治疗的现状
JACC Asia. 2025 Mar;5(3 Pt 2):405-423. doi: 10.1016/j.jacasi.2024.10.008. Epub 2024 Dec 17.
2
Tricuspid regurgitation: Innovation, current landscape, and future perspective of transcatheter tricuspid valve interventions.三尖瓣反流：经导管三尖瓣介入治疗的创新、现状及未来展望
J Cardiol. 2025 Mar 17. doi: 10.1016/j.jjcc.2025.03.009.
3
Emerging Transcatheter Therapies for Valvular Heart Disease: Focus on Mitral and Tricuspid Valve Procedures.用于心脏瓣膜病的新兴经导管治疗：聚焦二尖瓣和三尖瓣手术
Life (Basel). 2024 Jul 2;14(7):842. doi: 10.3390/life14070842.
4
Advances in transcatheter mitral and tricuspid therapies.经导管二尖瓣和三尖瓣治疗的进展。
BMC Cardiovasc Disord. 2020 Jan 7;20(1):1. doi: 10.1186/s12872-019-01312-3.
5
Functional Tricuspid Regurgitation in the Transcatheter Aortic Valve Replacement Population and Emerging Transcatheter Tricuspid Valve Interventions.经导管主动脉瓣置换术人群中的功能性三尖瓣反流及新兴的经导管三尖瓣介入治疗
US Cardiol. 2024 Sep 18;18:e16. doi: 10.15420/usc.2023.24. eCollection 2024.
6
Update on Transcatheter Treatment of Mitral and Tricuspid Valve Regurgitation.经导管二尖瓣和三尖瓣反流治疗的最新进展。
Curr Cardiol Rep. 2023 Oct;25(10):1361-1371. doi: 10.1007/s11886-023-01954-y. Epub 2023 Sep 12.
7
Diagnosis: Tricuspid Regurgitation. Next Steps.诊断：三尖瓣反流。下一步措施。
Am J Med. 2025 Feb 13. doi: 10.1016/j.amjmed.2025.02.006.
8
A focus on the percutaneous therapy of mitral and tricuspid regurgitation.聚焦二尖瓣和三尖瓣反流的经皮治疗。
Eur Heart J Suppl. 2023 Apr 21;25(Suppl B):B155-B160. doi: 10.1093/eurheartjsupp/suad095. eCollection 2023 Apr.
9
Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence.经导管治疗三尖瓣反流：当代证据综述
Heart Int. 2024 Dec 18;18(2):24-36. doi: 10.17925/HI.2024.18.2.4. eCollection 2024.
10
Transcatheter Tricuspid and Pulmonary Valve Repair and Replacement.经导管三尖瓣和肺动脉瓣修复与置换
Surg Technol Int. 2020 May 28;36:217-223.

引用本文的文献

1
Epidemiology of Valvular Heart Disease in Asia Pacific Region.亚太地区心脏瓣膜病流行病学
JACC Asia. 2025 May 3;5(6):718-43. doi: 10.1016/j.jacasi.2025.03.011.
2
Another Engine to Advance the Development of Structural Heart Interventions: A Special Issue to Grow With the China Valve.推动结构性心脏病介入治疗发展的另一引擎：与中国瓣膜共同成长的特刊
JACC Case Rep. 2025 May 14;30(10):104017. doi: 10.1016/j.jaccas.2025.104017.
3
The Evolving Landscape of Tricuspid Regurgitation Management.三尖瓣反流管理的发展态势

本文引用的文献

1
Structural Heart Imaging Using 3-Dimensional Intracardiac Echocardiography: JACC: Cardiovascular Imaging Position Statement.使用三维心内超声心动图的心脏结构成像：美国心脏病学会杂志：心血管成像立场声明。
JACC Cardiovasc Imaging. 2025 Jan;18(1):93-115. doi: 10.1016/j.jcmg.2024.05.012. Epub 2024 Jun 6.
2
Tricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art Review.射血分数保留的心力衰竭患者的三尖瓣反流：美国心脏病学会的现状评估。
J Am Coll Cardiol. 2024 Jul 9;84(2):195-212. doi: 10.1016/j.jacc.2024.04.047.
3
30-Day Outcomes of Transcatheter Tricuspid Annuloplasty With the K-Clip System: A Single-Center, Observational Study.
JACC Asia. 2025 Mar;5(3 Pt 2):401-404. doi: 10.1016/j.jacasi.2025.02.008.
使用K夹系统经导管三尖瓣环成形术的30天结局：一项单中心观察性研究
JACC Adv. 2023 Oct 27;2(9):100671. doi: 10.1016/j.jacadv.2023.100671. eCollection 2023 Nov.
4
Transcatheter Edge-to-Edge Approach to Repair Large Coaptation Gaps: The Zipping Technique.经导管边缘对边缘修复大瓣叶贴合间隙：拉链技术
JACC Cardiovasc Interv. 2024 Jun 24;17(12):1502-1504. doi: 10.1016/j.jcin.2024.04.007. Epub 2024 Jun 5.
5
GLIDE Score: Scoring System for Prediction of Procedural Success in Tricuspid Valve Transcatheter Edge-to-Edge Repair.GLIDE 评分：三尖瓣经导管缘对缘修复术术中成功率预测评分系统。
JACC Cardiovasc Imaging. 2024 Jul;17(7):729-742. doi: 10.1016/j.jcmg.2024.04.008. Epub 2024 Jun 5.
6
Real-World 1-Year Results of Tricuspid Edge-to-Edge Repair From the bRIGHT Study.bRIGHT 研究的三尖瓣缘对缘修复的真实世界 1 年结果。
J Am Coll Cardiol. 2024 Aug 13;84(7):607-616. doi: 10.1016/j.jacc.2024.05.006. Epub 2024 May 15.
7
Managing Implanted Cardiac Electronic Devices in Patients With Severe Tricuspid Regurgitation: JACC State-of-the-Art Review.管理严重三尖瓣反流患者的植入性心脏电子设备：JACC 最新技术评价。
J Am Coll Cardiol. 2024 May 21;83(20):2002-2014. doi: 10.1016/j.jacc.2024.02.045.
8
Feasibility of Using TriClip Guide for Combined MitraClip and TriClip Transcatheter Edge-to-Edge Repair: First-in-Human Experience.使用TriClip引导器进行MitraClip和TriClip经导管缘对缘联合修复的可行性：首例人体经验
JACC Cardiovasc Interv. 2024 Apr 22;17(8):1071-1072. doi: 10.1016/j.jcin.2024.02.024.
9
LuX-Valve Plus transcatheter tricuspid valve replacement for massive tricuspid flail after lead extraction.LuX-Valve Plus经导管三尖瓣置换术用于导线拔除后严重三尖瓣连枷样病变
Eur Heart J. 2024 Jun 1;45(21):1958. doi: 10.1093/eurheartj/ehae165.
10
Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.三尖瓣继发于房性的反流：病理生理学、定义、诊断和治疗。
Eur Heart J. 2024 Mar 14;45(11):895-911. doi: 10.1093/eurheartj/ehae088.